The combination of obesity and hypertension: A highly unfavorable phenotype requiring attention

Current Opinion in Cardiology

Volumn 31, Issue 4, 2016, Pages 394-401

  Arena, Ross ^a   Daugherty, John ^a   Bond, Samantha ^a   Lavie, Carl J ^b   Phillips, Shane ^a   Borghi Silva, Audrey ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Bariatric surgery; Diet; Exercise; Healthy lifestyle; Renal disease; Weight loss

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADRENERGIC SYSTEM; BARIATRIC SURGERY; BODY MASS; ENDOTHELIUM; EXCESS BODY MASS; EXERCISE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LIFESTYLE; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SLEEP DISORDERED BREATHING; WEIGHT REDUCTION; BODY COMPOSITION;

BODY COMPOSITION; HUMANS; HYPERTENSION; OBESITY; OVERWEIGHT; PHENOTYPE;

EID: 84963660216     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000294     Document Type: Review

References (72)

1. Wagner KH, Brath H. A global view on the development of non communicable diseases. Prev Med 2012; 54 (Suppl):S38-S41.
2. Thomas B, Gostin LO. Tackling the global NCD crisis: innovations in law and governance. J Law Med Ethics 2013; 41:16-27.
3. Roura LC, Arulkumaran SS. Facing the noncommunicable disease (NCD) global epidemic - the battle of prevention starts in utero - the FIGO challenge. Best Pract Res Clin Obstet Gynaecol 2015; 29:5-14. Addresses the forward moving healthcare strategy that must be embraced: primordial prevention.
4. Matheson GO, Klugl M, Engebretsen L, et al. Prevention and management of noncommunicable disease: the IOC consensus statement, Lausanne 2013. Brit J Sports Med 2013; 47:1003-1011.
5. Lloyd-Jones DM, Hong Y, Labarthe D, et al., American Heart Association Strategic Planning Task F and Statistics C. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586-613.
6. Arena R, Whitsel LP, Berra K, et al. Healthy lifestyle interventions to combat non-communicable disease: a novel non-hierarchical connectivity model for key stakeholders: a policy statement from the AHA, ESC, EACPR and ACPM. Mayo Clin Proc 2015; 90:1082-1103. Provides a framework for new collaborative models for healthy lifestyle interventions.
7. Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007-2012. JAMA Int Med 2015; 175:1412-1413.
8. Obesity Fact Sheet. http://www.who.int/mediacentre/factsheets/fs311/en/. [Accessed 6 May 2015]
9. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics - 2015 update: A report from the American Heart Association. Circulation 2015; 131:e29-e322. Published annually, this update is an excellent resource for cardiovascular statistics and associated risk factors.
10. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-781.
11. Masters RK, Reither EN, Powers DA, et al. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health 2013; 103:1895-1901.
12. Dobbs R, Sawers C, Thompson F, et al. Overcoming obesity: an initial economic analysis. Report from the McKinsey Global Institute 2014. http://www.mckinsey.com/-/media/McKinsey/Business%20Functions/Economic% 20Studies%20TEMP/Our%20Insights/How%20the%20world%20 could%20better%20fight%20obesity/MGI-Overcoming-obesity-Full-report. ashx. [Accessed 31 March 2016]
13. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224-2260.
14. Global Health Observatory (GHO) data: Raised blood pressure. http:// www.who.int/gho/ncd/risk-factors/blood-pressure-prevalence-text/en/. [Accessed 26 June 2015]
15. World Health Organization. A global brief on hypertension: silent killer, global public health crisis; 2013. http://www.who.int/cardiovascular-diseases/ publications/global-brief-hypertension/en/. [Accessed 31 March 2016]
16. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet 2015; 386:801-812.
17. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23:1170-1178.
18. Kotsis V, Stabouli S, Papakatsika S, et al. Mechanisms of obesity-induced hypertension. Hypertens Res 2010; 33:386-393.
19. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009; 93:733-751.
20. Narkiewicz K. Obesity, hypertension - the issue is more complex than we thought. Nephrol Dial Transplant 2006; 21:264-267.
21. Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment. J Clin Hypertens 2013; 15:14-33.
22. Wirix AJ, Kaspers PJ, Nauta J, et al. Pathophysiology of hypertension in obese children: a systematic review. Obes Rev 2015; 16:831-842.
23. Hall JE, do Carmo JM, da Silva AA, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015; 116:991-1006. Excellent review for the link between obesity and hypertension.
24. Lambert EA, Straznicky NE, Dixon JB, Lambert GW. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol 2015; 309:H244-H258.
25. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106:2533-2536.
26. Thorp AA, Schlaich MP. Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res 2015; 2015:341583.
27. Naguib MT. Kidney disease in the obese patient. South Med J 2014; 107:481-485.
28. Snyder S, Turner GA, Turner A. Obesity-related kidney disease. Prim Care 2014; 41:875-893.
29. Kalupahana NS, Moustaid-Moussa N. The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol 2012; 47:379-390.
30. Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem 2013; 24:2003-2015.
31. Kappus RM, Fahs CA, Smith D, et al. Obesity and overweight associated with increased carotid diameter and decreased arterial function in young otherwise healthy men. Am J Hypertens 2014; 27:628-634.
32. Wise J. 'Tsunami of obesity' threatens all regions of world, researchers find. BMJ 2011; 342:d772.
33. Wofford MR, Smith G, Minor DS. The treatment of hypertension in obese patients. Curr Hypertens Rep 2008; 10:143-150.
34. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes 2013; 6:327-338.
35. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation 2014; 130:1692-1699.
36. Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014; 11:507-515.
37. Arena R, Whitsel LP, Berra K, et al. Healthy lifestyle interventions to combat non-communicable disease: a novel non-hierarchical connectivity model for key stakeholders: a policy statement from the AHA, ESC, EACPR and ACPM. Eur Heart J 2015; 36:2097-2109. Provides a framework for new collaborative models for healthy lifestyle interventions.
38. Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011; 377:529-532.
39. World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020; 2013. http://www.who.int/nmh/events/ncd-action- plan/en/. [Accessed 31 March 2016]
40. Liu J, Sui X, et al. Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. J Am Coll Cardiol 2014; 64:1245-1253.
41. Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014; 63:1345-1354.
42. Schwingshackl L, Dias S, Hoffmann G. Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network meta-analysis. Syst Rev 2014; 3:130.
43. Nurkkala M, Kaikkonen K, Vanhala ML, et al. Lifestyle intervention has a beneficial effect on eating behavior and long-term weight loss in obese adults. Eat Behav 2015; 18:179-185.
44. Newton RL, Griffith DM, Kearney WB, Bennett GG. A systematic review of weight loss, physical activity and dietary interventions involving African American men. Obes Rev 2014; 15:93-106. Current review of efficacy of lifestyle interventions.
45. Clark JE. Diet, exercise or diet with exercise: comparing the effectiveness of treatment options for weight-loss and changes in fitness for adults (18-65 years old) who are overfat, or obese; systematic review and meta-analysis. J Diabetes Metab Disord 2015; 14:31.
46. Ades PA, Savage PD, Harvey-Berino J. The treatment of obesity in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2010; 30:289-298.
47. Ades PA, Savage PD, Toth MJ, et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation 2009; 119:2671-2678.
48. Looney SM, Raynor HA. Behavioral lifestyle intervention in the treatment of obesity. Health Serv Insights 2013; 6:15-31.
49. Ades PA. A lifestyle program of exercise and weight loss is effective in preventing and treating type 2 diabetes mellitus: Why are programs not more available? Prev Med 2015; 80:50-52. Highlights the importance of expanding opportunities for healthy lifestyle interventions.
50. Spahn JM, Reeves RS, Keim KS, et al. State of the evidence regarding behavior change theories and strategies in nutrition counseling to facilitate health and food behavior change. J Am Diet Assoc 2010; 110:879-891.
51. Lucini D, Cesana G, Vigo C, et al. Reducing weight in an internal medicine outpatient clinic using a lifestyle medicine approach: a proof of concept. Eur J Intern Med 2015; 26:680-684.
52. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: recommendation, statement. Am Fam Physician 2015; 191:587-593.
53. Voulgari C, Pagoni S, Vinik A, Poirier P. Exercise improves cardiac autonomic function in obesity and diabetes. Metabolism 2013; 62:609-621.
54. de Jonge L, Moreira EAM, Martin CK, et al. Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity 2010; 18:414-416.
55. Hegde SM, Solomon SD. Influence of physical activity on hypertension and cardiac structure and function. Curr Hypertens Rep 2015; 17:588.
56. Phillips SA, Mahmoud AM, Brown MD, Haus JM. Exercise interventions and peripheral arterial function: implications for cardio-metabolic disease. Prog Cardiovasc Dis 2015; 57:521-534.
57. Swift DL, Johannsen NM, Lavie CJ, et al. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2014; 56:441-447.
58. Tham JC, le Roux CW, Docherty NG. Cardiovascular, renal and overall health outcomes after bariatric surgery. Curr Cardiol Rep 2015; 17:34.
59. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane DB Syst Rev 2014; 8:CD003641.
60. Petersen KS, Blanch N, Keogh JB, Clifton PM. Effect of weight loss on pulse wave velocity: systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2015; 35:243-252.
61. Boido A, Ceriani V, Cetta F, et al. Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. Nutr Metab Cardiovasc Dis 2015; 25:437-443.
62. Jassil FC, Manning S, Lewis N, et al. Feasibility and impact of a combined supervised exercise and nutritional-behavioral intervention following bariatric surgery: a pilot study. J Obes 2015; 2015:693829.
63. Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014; 56:465-472.
64. Coen PM, Goodpaster BH. A role for exercise after bariatric surgery? Diabetes Obes Metab 2015; 18:16-23.
65. Arena R, Lavie CJ. The healthy lifestyle team is central to the success of accountable care organizations. Mayo Clin Proc 2015; 90:572-576.
66. Butsch WS. Obesity medications: what does the future look like? Curr Opin Endocrinol Diabetes Obes 2015; 22:360-366. Current review of obesity-focussed pharmacology.
67. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53:1925-1932.
68. Lavie CJ, Milani RV, O'Keefe JH. The Russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J 2008; 8:108-113.
69. Artham SM, Lavie CJ, Milani RV, et al. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009; 52:153-167.
70. Lavie CJ, Patel DA, Milani RV, et al. Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis 2014; 57:3-9.
71. DiNicolantonio JJ, Fares H, Niazi AK, et al. Beta-blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart 2015; 2:e000230.
72. Marcus JA, Pothineni A, Marcus CZ, Bisognano JD. The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep 2014; 16:411.